Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symplur is a healthcare-specific social media analytics company that provides deep insights into the global healthcare conversation. The company's proprietary Healthcare Social Graph platform maps the influence and interactions of various stakeholders, including physicians, patients, and caregivers, across social media channels. By analyzing millions of healthcare-related data points, Symplur helps pharmaceutical companies, healthcare organizations, and academic researchers understand trending topics and identify key opinion leaders. In 2020, Symplur was acquired by W2O Group (now Real Chemistry) to enhance its data-driven marketing and communications capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symplur.